BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10435803)

  • 1. Treatment of squamous cell anal canal carcinoma with pulsed dose rate brachytherapy. Feasibility study of a French cooperative group.
    Gerard JP; Mauro F; Thomas L; Castelain B; Mazeron JJ; Ardiet JM; Peiffert D
    Radiother Oncol; 1999 May; 51(2):129-31. PubMed ID: 10435803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of squamous cell anal canal carcinoma (SCACC) with pulsed dose rate brachytherapy: a retrospective study.
    Bruna A; Gastelblum P; Thomas L; Chapet O; Bollet MA; Ardiet JM; Gérard JP; Peiffert D
    Radiother Oncol; 2006 Apr; 79(1):75-9. PubMed ID: 16631268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with split-course external beam irradiation +/- chemotherapy and integrated Ir-192 high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal.
    Kapp KS; Geyer E; Gebhart FH; Oechs AC; Berger A; Hebenstreit J; Stoeger H
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):997-1005. PubMed ID: 11240240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interstitial pulsed-dose-rate brachytherapy for the treatment of squamous cell anal carcinoma: A retrospective single institution analysis.
    Boukhelif W; Ferri-Molina M; Mazeron R; Maroun P; Duhamel-Oberlander AS; Dumas I; Martinetti F; Guemnie-Tafo A; Chargari C; Haie-Meder C
    Brachytherapy; 2015; 14(4):549-53. PubMed ID: 25935731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients.
    Touboul E; Schlienger M; Buffat L; Lefkopoulos D; Pène F; Parc R; Tiret E; Gallot D; Malafosse M; Laugier A
    Cancer; 1994 Mar; 73(6):1569-79. PubMed ID: 8156483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose-rate interstitial brachytherapy boost for the treatment of anal canal cancers.
    Cordoba A; Escande A; Leroy T; Mirabel X; Coche-Dequéant B; Lartigau E
    Brachytherapy; 2017; 16(1):230-235. PubMed ID: 27600606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidermoid carcinomas of the anal canal treated with definitive radiation therapy in a series of 305 patients].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Houry S; Gallot D; Parc R; Huang R; Qu SH; Pène F; Schlienger M
    Cancer Radiother; 2003 Aug; 7(4):237-53. PubMed ID: 12914857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Brachytherapy for anal cancers].
    Pommier P; Mirabel X; Hannoun-Lévi JM; Malet C; Gérard JP; Peiffert D
    Cancer Radiother; 2013 Apr; 17(2):143-50. PubMed ID: 23582604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.
    Gaspar LE; Qian C; Kocha WI; Coia LR; Herskovic A; Graham M
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):593-9. PubMed ID: 9112458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients.
    Gerard JP; Ayzac L; Hun D; Romestaing P; Coquard R; Ardiet JM; Mornex F
    Radiother Oncol; 1998 Mar; 46(3):249-56. PubMed ID: 9572617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial hyperthermia and high dose rate brachytherapy in the treatment of anal cancer: a phase I/II study.
    Kapp KS; Kapp DS; Stuecklschweiger G; Berger A; Geyer E
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):189-99. PubMed ID: 8270441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Squamous cell carcinoma of the anal canal.
    Mitchell SE; Mendenhall WM; Zlotecki RA; Carroll RR
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1007-13. PubMed ID: 11240241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twenty-year experience in the management of squamous cell anal canal carcinoma with interstitial brachytherapy.
    López Guerra JL; Lozano AJ; Pera J; Gutiérrez C; Cambray M; Ferrer F; Guedea F
    Clin Transl Oncol; 2011 Jul; 13(7):472-9. PubMed ID: 21775274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [External beam radiation therapy and interstitial brachytherapy in the treatment of anal canal carcinomas: a series of 70 patients].
    Dubois JB; Azria D; Ychou M
    Bull Cancer; 2003 Dec; 90(12):1107-10. PubMed ID: 14715430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial iridium-192 implantation combined with external radiotherapy in anal cancer: ten years experience.
    Sandhu AP; Symonds RP; Robertson AG; Reed NS; McNee SG; Paul J
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):575-81. PubMed ID: 9486607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial high-dose rate brachytherapy as boost for anal canal cancer.
    Falk AT; Claren A; Benezery K; François E; Gautier M; Gerard JP; Hannoun-Levi JM
    Radiat Oncol; 2014 Nov; 9():240. PubMed ID: 25377886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiotherapy of carcinomas of the anal canal. Tenon Hospital experience].
    Touboul E; Moureau-Zabotto L; Lerouge D; Pène F; Deniaud-Alexandre E; Tiret E; Sezeur A; Houry S; Gallot D; Parc R; Schlienger M; Laugier A
    Cancer Radiother; 2003 Nov; 7 Suppl 1():91s-99s. PubMed ID: 15124550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy.
    Weber DC; Kurtz JM; Allal AS
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):675-80. PubMed ID: 11395235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.